QUECLEDE Trademark

Trademark Overview

On Thursday, May 15, 2014, a trademark application was filed for QUECLEDE with the United States Patent and Trademark Office. The USPTO has given the QUECLEDE trademark a serial number of 86282446. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 1, 2024. This trademark is owned by Glaxo Group Limited. The QUECLEDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
queclede

General Information

Serial Number86282446
Word MarkQUECLEDE
Filing DateThursday, May 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 1, 2024
Registration Number5263190
Registration DateTuesday, August 15, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, March 1, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, July 12, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 12, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 12, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, October 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2016SOU EXTENSION 3 GRANTED
Monday, September 12, 2016SOU EXTENSION 3 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Saturday, April 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 22, 2016SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2016SOU EXTENSION 2 FILED
Wednesday, April 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 16, 2016SOU TEAS EXTENSION RECEIVED
Thursday, September 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2015SOU EXTENSION 1 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 1 FILED
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 9, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 31, 2014ASSIGNED TO LIE
Saturday, December 13, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 12, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 11, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 11, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 29, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 29, 2014LETTER OF SUSPENSION E-MAILED
Friday, August 29, 2014SUSPENSION LETTER WRITTEN
Friday, August 29, 2014ASSIGNED TO EXAMINER
Thursday, May 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 19, 2014NEW APPLICATION ENTERED

Related Keywords

queclede pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological